89 related articles for article (PubMed ID: 18049186)
1. Papanicolaou smears induce partial immunity against sexually transmitted viral infections.
Shapiro S; Hoffman M; Constant D; Rosenberg L; Carrara H; Allan BR; Marais DJ; Passmore JA; Williamson AL
Epidemiology; 2007 Nov; 18(6):709-15. PubMed ID: 18049186
[TBL] [Abstract][Full Text] [Related]
2. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women.
Nielsen A; Kjaer SK; Munk C; Iftner T
Sex Transm Dis; 2008 Mar; 35(3):276-82. PubMed ID: 18091564
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy.
Ammatuna P; Giovannelli L; Matranga D; Ciriminna S; Perino A
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2002-6. PubMed ID: 18708390
[TBL] [Abstract][Full Text] [Related]
4. Hypothesis: the act of taking a Papanicolaou smear reduces the prevalence of human papillomavirus infection: a potential impact on the risk of cervical cancer.
Shapiro S; Carrara H; Allan BR; Hoffman M; Rosenberg L; Kelly JP; Cooper DD; Williamson AL
Cancer Causes Control; 2003 Dec; 14(10):953-7. PubMed ID: 14750534
[TBL] [Abstract][Full Text] [Related]
5. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys.
Vaccarella S; Herrero R; Snijders PJ; Dai M; Thomas JO; Hieu NT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Muñoz N; Meijer CJ; Franceschi S;
Int J Epidemiol; 2008 Jun; 37(3):536-46. PubMed ID: 18316350
[TBL] [Abstract][Full Text] [Related]
6. Informational needs and the experiences of women with abnormal Papanicolaou smears.
Bertram CC; Magnussen L
J Am Acad Nurse Pract; 2008 Sep; 20(9):455-62. PubMed ID: 18786022
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy).
Masia G; Mazzoleni AP; Contu G; Laconi S; Minerba L; Montixi S; Montis F; Onano A; Porcedda E; Coppola RC
Vaccine; 2009 May; 27 Suppl 1():A11-6. PubMed ID: 19480954
[TBL] [Abstract][Full Text] [Related]
8. HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women.
Vanslyke JG; Baum J; Plaza V; Otero M; Wheeler C; Helitzer DL
Qual Health Res; 2008 May; 18(5):584-96. PubMed ID: 18337618
[TBL] [Abstract][Full Text] [Related]
9. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
11. Age at sexual initiation and number of sexual partners in the female Spanish population Results from the AFRODITA survey.
de Sanjose S; Cortés X; Méndez C; Puig-Tintore L; Torné A; Roura E; Bosch FX; Castellsague X
Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):234-40. PubMed ID: 18499332
[TBL] [Abstract][Full Text] [Related]
12. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
13. Papanicolaou testing among Vietnamese Americans: results of a multifaceted intervention.
Nguyen TT; McPhee SJ; Gildengorin G; Nguyen T; Wong C; Lai KQ; Lam H; Mock J; Luong TN; Bui-Tong N; Ha-Iaconis T
Am J Prev Med; 2006 Jul; 31(1):1-9. PubMed ID: 16777536
[TBL] [Abstract][Full Text] [Related]
14. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda.
Safaeian M; Kiddugavu M; Gravitt PE; Gange SJ; Ssekasanvu J; Murokora D; Sklar M; Serwadda D; Wawer MJ; Shah KV; Gray R
Sex Transm Infect; 2008 Aug; 84(4):306-11. PubMed ID: 18385223
[TBL] [Abstract][Full Text] [Related]
16. High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older.
Bansal M; Austin RM; Zhao C
Gynecol Oncol; 2009 Nov; 115(2):257-61. PubMed ID: 19665217
[TBL] [Abstract][Full Text] [Related]
17. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
18. The integration of STD/HIV services with contraceptive services for young women in the United States.
Farr SL; Kraft JM; Warner L; Anderson JE; Jamieson DJ
Am J Obstet Gynecol; 2009 Aug; 201(2):142.e1-8. PubMed ID: 19481723
[TBL] [Abstract][Full Text] [Related]
19. [Updated cervical cancer screening; human papilloma virus and Papanicolaou tests].
Sasagawa T
Rinsho Byori; 2009 Sep; 57(9):905-12. PubMed ID: 19860220
[TBL] [Abstract][Full Text] [Related]
20. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
